MCI: mild cognitive impairment, AD: Alzheimer's disease, Mixed Dementia: AD mixed cerebrovascular disease, DLB: Lewy bodies. Image from "Matsushita et al." and is licensed under CC BY 4.0 This ...

They essentially mirror the same type of forgetfulness ... needs into account. Stage 4: Moderate Cognitive Decline Causes ...

Our easy-to-read patient fact sheet provides clinicians with information on the symptoms of delirium vs dementia and AD.

Different types of dementia require different approaches and management. Among a long list of the differential diagnosis of dementia, four common diseases (Alzheimer's disease, vascular dementia ...

Here are 4 tips to help you communicate more effectively ... their presence Instead of assuming that people with dementia need a certain type of communication, consider each person’s unique ...

They combined data from two large-scale population-representative studies that analyzed the diets and cognitive function of more than 10,000 participants ages 55 and older from China and the U.S. The ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

In the UK, there are four medications approved to ease some dementia symptoms: donepezil, rivastigmine, galantamine and memantine. Which medication is prescribed may depend on a number of factors, ...

To investigate the drug’s links to dementia risk, the researchers compared people with type 2 diabetes taking SGLT-2 inhibitors with those taking dipeptidyl peptidase-4 (DPP-4) inhibitors.

There are four medications approved in the UK to ease a person ... Parkinson’s disease dementia, and mixed dementia involving any of these types. There aren’t yet any medications that improve the ...

Most participants consumed four to five daily ... scores had a lower risk of dementia compared to those with the lowest flavodiet scores. In studying several types of flavonoids, the researchers ...

With previous research showing treatment with SGLT-2 inhibitors was associated with a greater reduction in the risk for dementia than DPP-4 treatment among people older than 66 years with type 2 ...